Calumet Specialty Products Partners (NASDAQ:CLMT) reported Q2 EPS of ($0.19), $0.34 worse than the analyst estimate of $0.15.
Calumet Specialty Products Partners (NASDAQ:CLMT) reported Q2 EPS of ($0.19), $0.34 worse than the analyst estimate of $0.15.